Perrigo - Best Pharma Stocks of 2007

Company: Perrigo
Starting stock price: $17.61
Ending stock price: $35.01
Percent Change: 98.81%

Details: Perrigo develops, manufactures and distributes OTC and prescription pharmaceuticals, nutritional products, active pharmaceutical ingredients and consumer products. In December 2007 Perrigo won FDA approval for an OTC, generic heartburn treatment the company will market in partnership with Dexcel Pharma.

More News:
Perrigo gets OK for generic heartburn drug. Report
Dexcel gets right to sell copycat Prilosec. Report

Perrigo - Best Pharma Stocks of 2007
Read more on

Suggested Articles

Pfizer isn't giving up in biosims. This week, it unveiled launches to three Roche blockbusters, with two already on the market.

Novo Nordisk is betting big on GLP-1 Saxenda in its global obesity push, but England's cost watchdog is unimpressed with the drug's long-term outlook.

Tecentriq didn’t show benefit against simple observation at delaying cancer recurrence or death in patients with muscle-invasive urothelial cancer.